<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>佰傲谷BioValley | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-08T13:25:58+08:00</updated>
  <subtitle>佰傲谷致力于打造一个垂直于生物制品领域的第三方平台。为生物制药企业提供品牌推广、技术咨询、项目交易、企业合作、人才培养等服务。为生物制药行业从业人员提供沟通交流、会议培训、工作求职、个人展示平台</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>2020ASH: 时隔一年， CD20xCD3双抗疗效仍然惊艳</title>
    <updated>2020-12-08T11:20:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/He1s2NRVctJq2OHZ_Tby3w</id>
    <link href="https://mp.weixin.qq.com/s/He1s2NRVctJq2OHZ_Tby3w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>柳叶刀：PD-1之后，膀胱癌患者有望迎来基因疗法</title>
    <updated>2020-12-08T11:20:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/5pX2ftbGG7_DaVtnCKp_cQ</id>
    <link href="https://mp.weixin.qq.com/s/5pX2ftbGG7_DaVtnCKp_cQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>间充质干细胞调节免疫和治疗工艺开发</title>
    <updated>2020-12-08T11:20:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/tR9-xXR5dMumSSwGtvZvkA</id>
    <link href="https://mp.weixin.qq.com/s/tR9-xXR5dMumSSwGtvZvkA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>雇佣条款未决争议，康宁杰瑞解聘CFO</title>
    <updated>2020-12-08T11:20:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/CG9VeBCSMFzU2AOs4kbMkg</id>
    <link href="https://mp.weixin.qq.com/s/CG9VeBCSMFzU2AOs4kbMkg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>License in 变质了吗？</title>
    <updated>2020-12-07T18:35:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/-hP1tUI2SNrW7k6pl-CcIw</id>
    <link href="https://mp.weixin.qq.com/s/-hP1tUI2SNrW7k6pl-CcIw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>网络直播 | 运用新型抗体文库开发针对几乎所有靶点的治疗药物</title>
    <updated>2020-12-07T18:35:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/HcsZpPJSqWmbYypslQ11UA</id>
    <link href="https://mp.weixin.qq.com/s/HcsZpPJSqWmbYypslQ11UA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新冠年终盘点：我们与COVID-19共处的这一年</title>
    <updated>2020-12-07T18:35:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/JoFxwuI-i8Bbgsq3qtwxXA</id>
    <link href="https://mp.weixin.qq.com/s/JoFxwuI-i8Bbgsq3qtwxXA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>沃森又不卖泽润了！原来爱情还可以抢救一下</title>
    <updated>2020-12-07T18:35:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/TFEY0ZtQMLymJYlur2vtcA</id>
    <link href="https://mp.weixin.qq.com/s/TFEY0ZtQMLymJYlur2vtcA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Bio-ONE精彩回顾 | 生物医药新型工艺大会是如何炼成的？</title>
    <updated>2020-12-06T16:00:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-06:/s/jc316qSu9IDC5IXHR13O4Q</id>
    <link href="https://mp.weixin.qq.com/s/jc316qSu9IDC5IXHR13O4Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>靶点药讯38|纵览全球药物靶点动态</title>
    <updated>2020-12-06T16:00:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-06:/s/Dq_LFiExWLv9QhenO7wRrA</id>
    <link href="https://mp.weixin.qq.com/s/Dq_LFiExWLv9QhenO7wRrA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“华为本为”正式进入生物药研发领域</title>
    <updated>2020-12-06T16:00:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-06:/s/aDyw-KcufpBRnVFTvqoYuA</id>
    <link href="https://mp.weixin.qq.com/s/aDyw-KcufpBRnVFTvqoYuA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>圆满落幕 | 2020Bio-ONE第二届生物医药新型工艺技术及应用高峰论坛顺利收官！</title>
    <updated>2020-12-05T19:30:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-05:/s/mpFU_lPBYK0VOXSB58bRxQ</id>
    <link href="https://mp.weixin.qq.com/s/mpFU_lPBYK0VOXSB58bRxQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>填补空白，EGFR 20号外显子突变肺癌患者有望迎来首款靶向药，强生向FDA递交其EGFR&amp;cMET双抗上市申请</title>
    <updated>2020-12-05T19:30:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-05:/s/63zU8xADF3JB2VJj9y4UpA</id>
    <link href="https://mp.weixin.qq.com/s/63zU8xADF3JB2VJj9y4UpA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>千人齐聚，干货不断！第二届生物医药新型工艺技术及应用高峰论坛在沪盛大开启</title>
    <updated>2020-12-04T21:17:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/-KChxR47x293V7inNN_2dA</id>
    <link href="https://mp.weixin.qq.com/s/-KChxR47x293V7inNN_2dA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020 Think Big 十佳入选项目专访 | 艾康药业</title>
    <updated>2020-12-04T21:17:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/ct4yNQZfIg22zFvE-iPaVQ</id>
    <link href="https://mp.weixin.qq.com/s/ct4yNQZfIg22zFvE-iPaVQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>佰傲谷 | 2020生物产业年度攀登榜颁奖晚宴</title>
    <updated>2020-12-04T21:17:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/dmUEObVkyX36Dt2D9EPv2w</id>
    <link href="https://mp.weixin.qq.com/s/dmUEObVkyX36Dt2D9EPv2w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>赋能生物产业，构建双选平台｜2020 Think Big生物医药创新项目路演活动精彩回顾</title>
    <updated>2020-12-03T16:24:12+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/cFUJHgprt7ZAYeeljQOS-w</id>
    <link href="https://mp.weixin.qq.com/s/cFUJHgprt7ZAYeeljQOS-w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>参会指南 | 第二届Bio-ONE生物医药新型工艺技术及应用高峰论坛</title>
    <updated>2020-12-03T16:24:12+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/yp-fHxjzc2UV2W45NapCmg</id>
    <link href="https://mp.weixin.qq.com/s/yp-fHxjzc2UV2W45NapCmg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>康方生物PD-1/CTLA-4双抗在MSI-H新辅助治疗中疗效远超联合用药！</title>
    <updated>2020-12-03T16:24:12+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/Jj4TAS010D791fdsld4Iug</id>
    <link href="https://mp.weixin.qq.com/s/Jj4TAS010D791fdsld4Iug" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>行业动态：迈邦生物（Medium Bank）生产基地建设即将启动</title>
    <updated>2020-12-03T16:24:12+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/Y0_24YZTX6cGnVKzjolRaw</id>
    <link href="https://mp.weixin.qq.com/s/Y0_24YZTX6cGnVKzjolRaw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>